肝硬化合并难治性腹水56例临床诊治分析  

作　　者：虞三乔 

机构地区：[1]四川省荣县人民医院,四川荣县643100

出　　处：《健康导报（医学版）》2015年第4期21-22,共2页

摘　　要：目的探讨肝硬化合并难治性腹水的临床诊治疗效以及治疗策略。方法将来我院治疗的肝硬化合并难治性腹水56位患者，通过随机分配．分为两组。两组患者各为28位患者，实验组和对照组，实验组采用腹水超滤浓缩回输技术进行治疗，对照组通过常规的腹腔穿刺术进行治疗，实验组与对照组的护理奈件相同，对比临床疗效结果经过治疗，实验组患者的康复状况明显好于对照组患者，将患者的治疗效果层次按照治疗结果分为显效、有效、无效三个层次，通过数据统计实验组显效的患者为13例，治疗效果为有效的为9例．治疗效果为无效的患者为1。例，对照组治疗效果为显效的患者为7例，治疗效果为有效的为10例，治疗效果为无效的患者为6例，实验组与对照组两组患者治疗效果的比较符合统计学差异（P〈0．05），两组患者常规肝硬化合并难治性腹水常规检测（血清蛋白、胆红素、血钾、血钠）指标的差异性具有明显的差异性（p〈0．05）．结论现代肝硬化合并难治性腹水的治疗技术中效果最好的是腹水超滤浓缩回输技术，与传统的腹腔穿刺放液治疗技术相比，它具有安全高效，治疗效果好、能有效的降低并发症的发生率，是现代肝硬化合并难治性腹水临床治疗的有效医疗方法。objective to explore the clinical curative effect of diagnosis and treatment ofhepatocirrhosis with intractable ascites, and treatment strategies.Methods in the future treatment ofhepatocirrhosis with intractable ascites, 56 patients with random distribution, divided into two groups, the experimental group, 28 patients in the control group of 22 patients, the experimental group and control group, experimental group treated with ascites ultrafiltration concentration doping technique, the control group treated by conventional abdominocentesis, experimental group and control group in the care of the same, compare the clinical results after treatment, the rehabilitation conditions of the experimental group significantly better than the control group patients, treatment effect level of the patients in accordance with the treatment results are divided into, effective and invalid three levels were markedly improved, through data statistical experimental group patients for 13 cases had marked effect, therapeutic effect for effective for 9 cases, treatment effect as invalid to 1, cases, control group therapy for patients for 6 cases had marked effect, therapeutic effect for effective for 10 cases, treatment effect for 6 patients with invalid, treatment effect of the experimental group and control group two groups of patients compared with statistical difference （ P 〈 0.05 ）, two groups of routine in patients with hepatocirrhosis with intractable ascites detection （ albumin, bilimbin, blood potassium, sodium ） index difference has the obvious difference （P 〈 0.05 ） .Conclusions the treatment of hepatocirrhosis with intractable ascites technology is best in ascites ultrafiltration concentration doping technique, compared with the traditional abdominal puncture fluid treatment technologies , it is safe and effective , good treatment effect , can effectively reduce the incidence ofcomplications, is the modern clinical treatment of hepatocirrhosis with intractable ascites of effective medical treatment method.

关 键 词：肝硬化 难治性肝腹水 腹腔穿刺放液 腹腔超滤浓缩回输 

分 类 号：R657.3[医药卫生—外科学]